Papers for
pharmaceutical ai developers
Papers whose findings have a practical use for this group, as judged from the abstract. Open a paper to read what it means in practice.
Ai systems struggle to understand chemical placeholders in patents
R-GroundBench: A Diagnostic Benchmark for R-Group Groundingin Markush Molecular Editing
Abstract: Recent advances in AI for scientific discovery enable molecular understandingand design, yet reasoning over incomplete chemical representations remainsunclear.Markush structures, which encode molecular families through variable R-groupplaceholders (\textit{R\textsubscript{1}}, \textit{R\textsubscript{2}}, \textit{X}, etc.), are ubiquitous in pharmaceutical patents and requiregrounding across molecular, textual, and chemical information.However, existing molecule-language benchmarks focus on fully specifiedmolecules, leaving R-group grounding largely unevaluated.We introduce R-GroundBench:, a diagnostic benchmark built from real patent Markushstructures, featuring a Multiple-Choice (VQA) track with controlled difficultyand modality splits, and an open-ended Generation track.Our results reveal a substantial gap between recognition andmolecular grounding.While models achieve over 90\% accuracy on Easy VQA, performance drops to56--66\% on Hard VQA when shortcuts are controlled.Chemical-domain VLMs also remain unreliable, achieving only 25.7--46.2\% on HardVQA despite domain-specific pretraining.Moreover, Generation Exact Match remains below 20\% for most models and below8\% when visual input is required.These findings reveal that current AI systems lack reliable grounding andexecution for Markush editing, highlighting challenges for AI-drivenscientific discovery.
Improving chemical image recognition reliability with verification and revision
ViCoR: Reliable Molecular Structure Extraction via Spatially Aligned Verification and Executable Revision
Abstract: Reliable optical chemical structure recognition (OCSR) is essential for building high-quality chemical data from scientific literature, yet even small recognition errors can propagate into chemical databases and downstream models. In practice, recognized structures often require manual inspection and correction before use, making large-scale data curation costly and difficult to scale. We therefore study Selective Structure Recognition (SSR), a post-recognition setting that automatically produces reliable structured outputs while rejecting unresolved cases. Selection-only approaches can improve reliability by rejection, but cannot create additional correct outputs beyond those produced by the base recognizer. We propose ViCoR, a repair-before-rejection framework for iterative VerIfiCatiOn and Revision. Its key idea is to make observation-prediction correspondence explicit: coordinate-preserving rendering establishes spatial correspondence between the source image and predicted structure, while index anchoring maps localized visual discrepancies to executable graph edits without full-structure regeneration. A shared VLM is progressively trained from verification to revision. On two real-world OCSR benchmarks, ViCoR improves overall accuracy from 73.53\% to 88.26\% and from 61.83\% to 84.32\%, while achieving over 97\% accepted accuracy at 85--89\% coverage. The resulting molecular data further improve reaction-extraction F1 by 15.5 points and literature-sourced reaction prediction accuracy by 7.7 and 5.8 points, demonstrating the value of automated reliability control for scientific data curation and downstream chemical learning.
Comparing deep learning models for designing new drug molecules
A Systematic Evaluation of Molecule Generation Models for De Novo Drug Design: From Benchmarks to Practical Insights
Abstract: Molecule generation has emerged as a powerful computational tool for de novo drug design, enabling the exploration of chemical space beyond the limits of conventional virtual screening. The field has progressed rapidly, driven by advances in molecular representations, generative architectures, and target-aware modeling strategies. However, existing reviews typically address specific model families or application scenarios in isolation, rather than offering an integrated perspective on how these components collectively form a coherent generation workflow. In this review, we present a comprehensive evaluation of molecule generation models for de novo drug design, covering 82 methods across five deep generative frameworks, including recurrent neural network (RNN)- and Transformer-based models, variational autoencoders (VAEs), generative adversarial networks (GANs), flow-based models, and diffusion models. We first summarize widely used benchmarks and molecular representations, and then examine the methodological principles underlying both general and pocket-conditioned generation. A central contribution of this work is a systematic synthesis and comparative analysis of reported performance across commonly used benchmarks and evaluation metrics. We also summarize representative experimentally validated case studies. Looking ahead, we discuss future directions in standardized 3D data, interaction-aware generation, receptor flexibility, and multi-objective molecular design, with the aim of improving the reliability and experimental relevance of molecule generation. All collected benchmark resources, evaluation metrics, and model references are provided in a publicly accessible repository at https://github.com/JacklinGroup/molecule-generation-review.